Phase I/II study of GC1008: A human anti-transforming growth factor-beta (TGFβ) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. C. Morris, G. I. Shapiro, A. R. Tan, D. P. Lawrence, T. E. Olencki, B. J. Dezube, F. J. Hsu, M. Reiss, J. A. Berzofsky
Language: English
Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2306753419
